Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I was in Lions Gate Entertainment Group (LGF) last year and they did a placement through Jefferies & Co, also. It seemed timed to the release of a few upcoming films, expected to be blockbusters. The price was set very constructively, if my memory serves me about 30% above the share price at the time. During the lead up of several months, the stock price marched up and beyond... and the films were big hits!
Not knowing the Offering Price, the amount of shares and over what period, it seems we have reason to stay positive.
MG
When I say longs I meant those who got in under 3.00 lol It will turn ARNA to a flip stock until FDA or the amount of shares will be PO
<The mistake ARNA did was to announce the PO before the FDA>
I agree. But why do it now? Why not wait until the approval? What was gained doing it this way?
<but a perfect set up for longs>
How is that? Are you suggesting someone long should not sell?
Tia
What??? VVUS did no such thing...lol
And that lepricon is the biggest crook of them all!!!
also i have noticed that there will always be leaks about secondaries, by definition they know one is coming since they are doing the deal. perhaps from people close to the IBs doing the secondaries. it is not fair but it is so. happened to me with amylin and amarin.
YOU SAID IT!! YOU ARE OVER SELLING ?? WONDER WHAT THE MOTIVE IS LOL
What ever the offerinig price is, wait for it to dive below it which will happen lol
if not today then tomorrow or any day a company decides to dilute.
what i mean is that the offering price of any secondary will be at a discount to the closing price of the day the announcement is made. however the stock price will recover (once the secondary event is over) if there are events that give people reason to buy.
It is not crooked it is strategic planning lol Crooked is when you dump than post PR
Just pray it is not more than 20million shares or this baby going down back to $3.00 or lower
Do not compare the two. VVUS has multiple drug thus any PO is a drop in the bucket.
SO YOU THINK BEING CROOKED IS A GOOD THING??
Many will bail out to wait for a lower SP to get back in. Many will wait for the PO share numbers to see how many shares will be hitting the common shares structure.
that I agree with. All I can say to that is WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE
regular Market might be lower all depend on long who were in under $4 will cash out to regain another low position post PO.
The mistake ARNA did was to announce the PO before the FDA. Most crooked BIO pharma wait until FDA. ARNA set up a bad situation for the new ARNA buyers, but a perfect set up for longs and short.
This is all about opex week. Nothing more.
This is opex week and the call writers are heavily exposed. They are trying to cause the May calls to close out of the money. This was very predictable. Take advantage; they are giving shares away.
stops dont get triggered AHs unless you have extended hours included in your stop sell order
you cant short AHs
so tomorrow will be interesting
underwriters are purchasing these shares, with the entitlement of purchasing more at/by a certain date. I had been involved in an offering once about 3 years ago. My shares were not able to trade on the open market for (1)one year. I had the option to purchase more at a certain price already determined before I purchased my original shares, these shares had a time limit to them. The reason for the restriction is so that the shares were not dumped on the open market, which would basically tank the company. ARNA is not stupid, I believe they are taking advantage of when the public is interested in them first of all. This is when they will make the most of their sales.
Second, the sales will increase the value of ARNA. This is enticing to other companies for any possible buy out, or if the drug is not approved for whatever reason the company will not tank because of it. ARNA could basically settle any debts, and look very favorable to a suitor.
If you check out http://www.eisai.com/news/news201224.html EISAI is also doing something interesting not sure what......
Either way, when you bought into this company, you invested your DD and time and money, for a return. I still believe that ARNA will be successful on 6-27. We may only see 18-20 dollars instead of 22-25 dollars, who knows. I personally will be taking advantage of these cheap shares.....glty
Just my 2 cents - I could very well be wrong but here is strong DD here and everywhere to make my 2 cents much stronger
IMO
They trip as many stop losses as possible - there is a big gap that could fill IMO but lovethatgreen has pointed out that arna has other gaps that haven't filled. So I'm guessing 4.50 - 5 is bottom and the back up from there and then it's a roller coaster till FDA meeting . But that's only my 2 cents
5cap, you are refusing to look at the hard facts.
Arna is diluting and the price they are diluting at is guaranteed to be lower than the closing price of today Tue May15 which is 6.06.
I believe VVUS did the same thing and their stock did just fine. It is not a bad idea for ARNA to get shares sold while there is an interest in the company. I still believe that even if ARNA did 20million, that still would dilute but we all shall still cash in nicely......not that I won't pick up more at the discounted price. However this will still get to 15-20 share.......glty
Oh and by the way there are not very many people who can day trade, so those who got caught at the higher end.......hang on you will still be rewarded........if people turned an ran after every little whim of news that appears to be bad then they wouldn't make any money......
What happens when ARNA opens tomorrow? Will it keep going down or have some legs and make up some of the A/H losses?
Thanks
Yes sir, gixxer. Those of us who did our homework months ago got into ARNA in the $1 and $2 range. We have made some excellent profits here and I think there will be more to be had before this story is over.
Half right?It is common stock but we didn't even get the F.D.A. approval.
<watchout for the infamous 8k after fda approval>
We will see . If you story comes true until then I have. To get back to work !!
Have a good night
It will. All small-bio always go PO
Sorry I don't listen to everyone on ihub buddy ... Your story hasn't come completely true yet ..
Once again I will say we all knew $7 wouldn't hold FOR NOW !!!
Glad to hear you took profit I also banked a large amount - and so did a lot of other people ..
go read my post with ARNA this week when I tried to warn you guys.
Selling my 1.89s lol at 3.60 and the left over the wife had at 7.10 premarket hahahah Than carry a short at 7.5 to now ride it down lol
Where we're you when this was climbing like a rabid banshee !!
Lol - funny how you show up when the PPS goes down ..
GLTY
We will see !! IMO I think you are wrong and you are here only because you hold a large amount in short position .. GLTY hope you ready ...everyone here knew 7 wouldn't hold give it time buddy ARNA will be back and you WILL BE FORCED TO COVER !!! Have your fun now before FDA approval ..
Just my opinion :)
People with short position above 7.50 will be dancing in the rain while those who hold under $2.00 will be helping shorts cover selling their position for profit before it tanks further.
that is people with profits getting out before ARNA announce the value of the PO.
You forget @ where most people hold positions well under 2 and mostly mid 2"s maybe some 3"s
Lmao - still a hell a profit @ 4
GLTY
5cap it is not too late. Call your broker and see if you can borrow shares to short. The value of the PO might be at $4. Good luck, because I am trying to get more shares to borrow increase my position. Who ever got short position above 7.5 will be rich.
So many people now have short position I can't find any brokage to loan me some shares pending the value of the public offering. MAN a whole lot of money will be made by shorters who have short position above 7.50.
IMO
If you want to make money off ARNA, do not buy yet. Wait for the value of the offering. Do not buy until the NAKED SHORTERS short ARNA down passed the public offering amount than buy.
WEEEEEEEEE I told you ARNA was going to pull a DSCO on your behind WEEEEEEEEEEEEEEEEEEEEEEEEEEE
Totally agree. Notice that no details are available, only the fact that they are working on it. So the IB plan could easily be an offering at $7 when the stock is at $8. I don't believe anyone is going to be able to buy millions of shares at $3, as the post I responded to was sort of implying. This has the feel that the company realized that some people knew about this financing and they thought they should get the word out.
This sure puts a little damper on things......
I still believe it will be approved....
Now at what price......?
In my experience, the offering price of a secondary is usually and almost always set at a discount to the current mkt price. The degree of discount is set (or advised to the company) by the leading investment banker(s) hired for the job. It is the job of the IBs to figure out how much they can sell for, meaning what kind of a price the mkt can/will support and that also depends on how many shares the company wish to sell.
Followers
|
259
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
22684
|
Created
|
03/27/07
|
Type
|
Free
|
Moderators |
ARENA PHARMACEUTICALS, Inc. (ARNA)
http://www.arenapharm.com/
http://finance.yahoo.com/q/h?s=ARNA
http://www.secform4.com/insider-trading/1080709.htm
Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of oral drugs for cardiovascular, central nervous system, inflammatory, and metabolic diseases. It is developing a pipeline of compounds targeting orphan G protein-coupled receptors using its drug discovery technologies, including constitutively activated receptor technology and Melanophore technology. The company?s drug candidate, lorcaserin hydrochloride, is in Phase 3 clinical trial program for the treatment of obesity. Its other lead development programs include APD125, a 5-HT2a serotonin receptor inverse agonist, which is in Phase 2 clinical trail for the treatment of insomnia; APD791, an anti-thrombotic drug candidate, which is in preclinical development stage for the treatment of arterial thromboembolic diseases, such as acute coronary syndrome. The company has collaboration agreements with Ortho-McNeil Pharmaceutical, Inc. for developing APD668, an orally administered drug candidate, which is under clinical development for the treatment of type 2 diabetes and other disorders; and with Merck & Co., Inc. for the development of MK-0354 for atherosclerosis and related disorders. Arena Pharmaceuticals was incorporated in 1997 and is based in San Diego, California.
http://finviz.com/quote.ashx?t=arna
>
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |